Affymetrix is now Applied Biosystems, a brand of DNA microarray products sold by Thermo Fisher Scientific that originated with an American biotechnology research and development and manufacturing company of the same name. The Santa Clara, California-based Affymetrix, Inc. now a part of Thermo Fisher Scientific was co-founded by Alex Zaffaroni and Stephen Fodor. Stephen Fodor and his group, based on their earlier development of methods to fabricate DNA microarrays using semiconductor manufacturing techniques.
Labcorp Drug Development is a contract research organization headquartered in Burlington, North Carolina, providing nonclinical, preclinical, clinical and commercialization services to pharmaceutical and biotechnology industries. Formerly called Covance, the company is part of Labcorp, which employs more than 70,000 people worldwide.
Providence Equity Partners L.L.C. is a specialist private equity investment firm focused on media, communications, education, and technology investments across North America and Europe. The firm specializes in growth-oriented private equity investments and has invested in more than 170 companies globally since its inception in 1989.
Fisher Scientific International, Inc. was a laboratory supply and biotechnology company that provided products and services to the global scientific research and clinical laboratory markets until its merger with Thermo Electron in 2006, after which it became Thermo Fisher Scientific. The company offered products and services to over 350,000 customers located in approximately 150 countries including pharmaceutical and biotechnology companies, secondary and higher education institutions, hospitals and medical research institutions, and quality control, process control and research and development laboratories.
Cellomics is the discipline of quantitative cell analysis using bioimaging methods and informatics with a workflow involving three major components: image acquisition, image analysis, and data visualization and management. These processes are generally automated. All three of these components depend on sophisticated software to acquire qualitative data, quantitative data, and the management of both images and data, respectively. Cellomics is also a trademarked term, which is often used interchangeably with high-content analysis (HCA) or high-content screening (HCS), but cellomics extends beyond HCA/HCS by incorporating sophisticated informatics tools.
QIAGEN is a German-founded multinational provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research. The company operates in more than 35 offices in over 25 countries. QIAGEN N.V., the global corporate headquarter of the QIAGEN group, is located in Venlo, The Netherlands. The main operative headquarters are located in Hilden, Germany. European, American, Chinese and Asian-Pacific regional headquarters are located in respectively Hilden, Germany; Germantown, Maryland, United States; Shanghai, China; and Singapore. QIAGEN's shares are listed at the NYSE and at the Frankfurt Stock Exchange in the Prime Standard. Thierry Bernard is the company's Chief Executive Officer (CEO).
David L. Grange is a retired United States Army major general. He served with the 101st Airborne Division during the Vietnam War. He was later assigned to Delta Force, commanding a squadron during the invasion of Grenada and was deputy commander during the Gulf War. His last command was of 1st Infantry Division before he retired in 1999.
IQVIA, formerly Quintiles and IMS Health, Inc., is an American Fortune 500 and S&P 500 multinational company serving the combined industries of health information technology and clinical research. IQVIA is a provider of biopharmaceutical development, professional consulting and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including investment strategy and management consulting services. It has a network of more than 88,000 employees in more than 100 countries and a market capitalization of US$49 billion as of August 2021. As of 2023, IQVIA was reported to be one of the world's largest contract research organizations (CRO).
Thermo Fisher Scientific Inc. is an American supplier of analytical instruments, life sciences solutions, specialty diagnostics, laboratory, pharmaceutical and biotechnology services. Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, and service providers, including Life Technologies Corporation (2013), Alfa Aesar (2015), Affymetrix (2016), FEI Company (2016), BD Advanced Bioprocessing (2018), and PPD (2021).
FEI Company is an American company that designs, manufactures, and supports microscope technology. Headquartered in Hillsboro, Oregon, FEI has over 2,800 employees and sales and service operations in more than 50 countries around the world. Formerly listed on the NASDAQ, it is a subsidiary of Thermo Fisher Scientific.
Riverbed Technology LLC is an American information technology company. Its products consist of software and hardware focused on Unified Observability, Network Visibility, End User Experience Management, network performance monitoring, application performance management, and wide area networks (WANs), including SD-WAN and WAN optimization.
Dharmacon Inc., now known as Dharmacon, was founded in 1995 by Stephen Scaringe as Dharmacon Research to develop and commercialize a new technology for RNA oligonucleotide synthesis. Originally, the company's focus was to develop 2'-ACE RNA technology as the standard for RNA synthesis and to advance RNA oligo-dependent applications and technologies.
Patheon is a service brand within Thermo Fisher Scientific’s brand portfolio. Contract development and manufacturing organization (CDMO) services offered under the Patheon brand include small molecule API, biologics, viral vectors, cGMP plasmids, formulation, clinical trials solutions, logistics and commercial manufacturing and packaging. In 2017, Patheon was acquired by Thermo Fisher Scientific to form its Pharma Services business.
RightChange.com was an American conservative political group. It was devoted to electing conservative U.S. Republican Party candidates, thus the reference to the political right in its name. It spent millions supporting Republican candidates in the 2010 general election.
Alfa Aesar, headquartered in Ward Hill, Massachusetts, United States, is a supplier of reagents and materials for use in research and development, and analysis. They have facilities in many countries and manufacture many of the chemicals they sell.
William G. Parrett is an American businessman and senior manager who has served public, private, governmental, and state-owned clients worldwide. In October 2008, Parrett was elected to the board of directors of UBS AG and, in November 2014, to the Board of Directors of UBS Group AG. In May 2018, he stepped down from this role and was focussing on the position of President of UBS Americas Holding LLC.
Dionex Corporation is an American company based in Sunnyvale, California. It develops, manufactures, sells, and services analytical chromatography systems for separating, isolating, and identifying the components of chemical mixtures. Such equipment is used in pharmaceutical manufacturing, medical research, environmental monitoring, and food testing.
Pierce Biotechnology Inc. is the ultimate origin of a number of products and product lines in the Thermo Fisher Scientific research and development division, "Thermo Scientific Pierce Protein Biology." The company from which this division originated, the Rockford, Illinois-based Pierce Chemical Company (PCC) was founded in 1948 when Alan Pierce assumed active management of a company known as Midwest Extraction, which focused on isolating chlorophyll from alfalfa.
Cole-Parmer Instrument Company, now known as Antylia Scientific, is a Company founded in 1955. The company serves professionals in biopharma, environmental and life sciences.
$4.7 Billion (2020) [2] 